Hamed Shahbazi keeps the ball rolling at Well Health Technologies

It’s safe to say that Well Health Techonologies (Well Health Techonologies Stock Quote, Chart TSXV:WELL) had a busy 2018 but there’s a lot more where that came from, according to CEO Hamed Shahbazi, who says he’s excited about his company’s scaling up.

Well Health, which is in the business of consolidating and modernizing health clinics across Canada, was a presenter at this year’s Cantech Investment Conference, held over two days this past week in Toronto.

The company is coming off a recent win in acquiring NerdEMR, the largest provider of OSCAR EMR (electronic medical records) services in the province of BC. That news came on top of the continuing growth of its stable of clinics and last year’s big investment from Hong Kong business magnate Li Ka-shing, all of which makes for exciting times for WELL, says Shahbazi, a known force in Canadian tech — in 2017 Shahbazi sold Tio Networks to PayPal for $304 million before taking up the reins at Well Health last May.

“We’re very excited,” says Shahbazi. “We’re out to acquire scale and really encourage synergy between the clinical and digital arms of our business. We think that this is a very strong asset class.”

“We want to be known as the WeWork for doctors because there’s an intense competition for physicians and whoever provides them with the best experience with the best journey is going to do really well in this space,” he says. “Over the past 12 months, our clinics have processed over 600,000 patient visits, so assuming that they’ll do the same over the next 12 months, we’re talking about a just shy of $30 million revenue business and that’s without additional enhancements or organic growth. And we have positive EBITDA across all of our clinics.”

Well Health released its interim fourth quarter 2018 results on December 21, featuring revenue from continuing operations of $1,911,625 and an Adjusted EBITDA loss from continuing operations of $537,219.

Disclosure: Cantech Letter’s Nick Waddell owns shares of WELL Health

Tagged with: well
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Ceragon Networks is a buy right now, this analyst says

Roth Capital Markets analyst Scott Searle maintained his “Buy” rating and $3.75 target on Ceragon Networks (Ceragon Networks Stock Quote,… [Read More]

24 hours ago

Time to dump your Celestica stock? Here’s what this analyst says

Ahead of Celestica’s first-quarter results due April 27, TD Cowen analyst John Shao raised his target on Celestica (Celestica Stock… [Read More]

24 hours ago

Telus will have “another life”, this investor says

On BNN Bloomberg Market Call on April 16, Newhaven Asset Management CEO and portfolio manager Ryan Bushell said Telus (Telus… [Read More]

1 day ago

Shopify is a great long-term investment, this investor says

On BNN Bloomberg Market Call on April 13, 5i Research head of research Chris White said Shopify (Shopify Stock Quote,… [Read More]

1 day ago

The analyst just launched coverage of Tiny with a “Buy”

Roth Capital Markets analyst Richard Baldry initiated coverage of Tiny Ltd. (Tiny Ltd. Stock Quote, Chart, News, Analysts, Financials TSXV:TINY)… [Read More]

2 days ago

Buy Decibel Cannabis for a double, this analyst says

Haywood analyst Neal Gilmer reiterated his “Buy” rating and $0.25 target on Decibel Cannabis Company (Decibel Cannabis Company Stock Quote,… [Read More]

2 days ago